BIOLNTELLISENSE, INC. – Trademark Portfolio
Entity Type: 03
BIOLNTELLISENSE, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include SAFESAT, ALERTWATCH, BIODASHBOARD, and BIOINTELLISENSE. The owner is based in GOLDEN, CO.
17301 W. COLFAX AVENUE, SUITE 152
GOLDEN, CO 80401
Showing of trademarks Trademarks
Trademark Classifications
BIOLNTELLISENSE, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does BIOLNTELLISENSE, INC. have?
BIOLNTELLISENSE, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 2 abandoned.
What trademark classes does BIOLNTELLISENSE, INC. file in?
BIOLNTELLISENSE, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are BIOLNTELLISENSE, INC.'s most well-known trademarks?
BIOLNTELLISENSE, INC.'s registered trademark portfolio includes well-known marks such as SAFESAT, ALERTWATCH, BIODASHBOARD, and BIOINTELLISENSE. These are among 4 currently registered trademarks in the portfolio.
What is BIOLNTELLISENSE, INC.'s trademark registration success rate?
BIOLNTELLISENSE, INC. has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.